Testing effectiveness (Phase 2)Study completedNCT04577638What this trial is testingAccelerated Radio-Immunotherapy for Lung CancerWho this might be right forNon Small Cell Lung Cancer Stage III Center Eugene Marquis 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05445843What this trial is testingStudy of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.Who this might be right forLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation Novartis Pharmaceuticals 95
Testing effectiveness (Phase 2)Ended earlyNCT02580708What this trial is testingPhase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Clovis Oncology, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00986674What this trial is testingCarboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung CancerWho this might be right forRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer National Cancer Institute (NCI) 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT02955290What this trial is testingCIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck CancerWho this might be right forAdvanced Head and Neck Squamous Cell CarcinomaLung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell Carcinoma+13 more Roswell Park Cancer Institute 51
Large-scale testing (Phase 3)Ended earlyNCT00442026What this trial is testingRandomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLCWho this might be right forNon-small-cell Lung Cancer Hellenic Oncology Research Group 106
Not applicableLooking for participantsNCT06436625What this trial is testingOutpatient Pulmonary Rehabilitation in Non-small-cell Lung Cancer Receiving ImmunotherapyWho this might be right forNSCLC Stage IV Karl Landsteiner Institute for Lung Research and Pneumological Oncology 70
Large-scale testing (Phase 3)Active Not RecruitingNCT04695925What this trial is testingOsimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 MutationsWho this might be right forNon-small Cell CarcinomaEGFR Gene Mutation Li Zhang, MD 294
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117What this trial is testingEvaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)Who this might be right forLocally Advanced or Metastatic Malignant Solid Tumors Astellas Pharma Global Development, Inc. 329
Not applicableStudy completedNCT01830426What this trial is testingCirculating Tumor Cells in Non-Small Cell Lung CarcinomaWho this might be right forPrimary Lung Cancer Epic Sciences 232
Testing effectiveness (Phase 2)Looking for participantsNCT05913089What this trial is testingA Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 58
Not applicableEnded earlyNCT00840749What this trial is testingRandomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Accuray Incorporated 36
Testing effectiveness (Phase 2)Study completedNCT02054052What this trial is testingIntrapleural Bevacizumab Injection for Malignant Effusion in Lung CancerWho this might be right forNon-small Cell Lung CancerMalignant Pleural Effusion Haihong Yang, MD, Pricipal investigator 22
Not applicableLooking for participantsNCT06975384What this trial is testingThe Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung CancerWho this might be right forLung CancerSleep DisturbanceImmune Checkpoint Inhibitors+1 more Second Xiangya Hospital of Central South University 1,270
Testing effectiveness (Phase 2)Looking for participantsNCT05798845What this trial is testingThe Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung CancerWho this might be right forNSCLC Shanghai Chest Hospital 124
Large-scale testing (Phase 3)Study completedNCT00556712What this trial is testingTarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 889
Large-scale testing (Phase 3)Study completedNCT00403065What this trial is testingDexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By SurgeryWho this might be right forLung CancerMetastatic Cancer Medical Research Council 1,000
Testing effectiveness (Phase 2)Study completedNCT00744900What this trial is testingPemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)Who this might be right forLung Cancer University Hospital, Brest 45
Testing effectiveness (Phase 2)Study completedNCT02403271What this trial is testingA Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid TumorsWho this might be right forNon-Small Cell Lung CancerBreast CancerPancreatic Cancer Pharmacyclics LLC. 124
Testing effectiveness (Phase 2)Ended earlyNCT02349633What this trial is testingStudy For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M)Who this might be right forNon-Small Cell Lung Cancer Pfizer 65